期刊文献+

篮式生物反应器制备Vero细胞乙型脑炎灭活疫苗 被引量:5

Preparation of Inactivated Japanese Encephalitis Vaccine with Vero Cells Cultured on Fibra Disk in Cellingen Plus
下载PDF
导出
摘要 目的建立篮式生物反应器制备Vero细胞乙型脑炎灭活疫苗的工艺。方法利用7.5L篮式生物反应器和片状载体培养Vero细胞,接种乙型脑炎病毒P3V2株毒种,根据葡萄糖的消耗量,分析细胞的生长情况及调节病毒培养时的灌流速度,每24h取样,检测病毒滴度。收获的病毒液经纯化后,制备乙脑灭活疫苗,检测各项指标。结果Vero细胞培养至96h,葡萄糖消耗量达高峰,细胞密度达峰值;接种病毒后72h,葡萄糖消耗量达高峰,灌流量为7L/d,连续收获7~9d,共可收获(40±5)L病毒液;96h病毒滴度达高峰,为10.0LgLD50/ml;制备的乙型脑炎灭活疫苗各项指标均达到《中国药典》三部(2005版)要求。结论已建立了篮式生物反应器制备Vero细胞乙型脑炎灭活疫苗的工艺。 Objective To develop a procedure for preparation of inactivated Japanese encephalitis (JE) vaccine with Vero cells cultured on Fibra disk in Cellingen Plus. Methods JE virus P3V2 seeds were inoculated to Vero cells cultured on Fibra disk in 7. 5 L Cellingen Plus. According to the consumption of glucose, the cell growth was analyzed, and the perfusion rate for virus culture was regulated. Samples were taken every 24 h for virus titration. The harvested virus liquid was purified to prepare inactivated JE vaccine. Overall control tests were performed on the prepared vaccine. Results Both glucose consumption and density of Vero cells reached peak values 96 h after culture. Seventy-two hours after inoculation of virus, glucose consumption reached a peak value, while the perfusion rate was 7 L/d. Virus liquid was harvested for 7 ~ 9 d and reached a total volume of (40 ± 5)L. The virus titer reached a peak value of 10. 0 LgLD50/ml 96 h after inoculation. All the quality indexes of prepared inactivated JE vaccine met the requirements in Chinese Pharmacopoeia (Volume Ⅲ, 2005 edition). Conclusion A procedure for preparation of inactivated JE vaccine with Vero cells cultured on Fibra disk in Cellingen Plus was developed.
出处 《中国生物制品学杂志》 CAS CSCD 2008年第12期1085-1086,1093,共3页 Chinese Journal of Biologicals
关键词 篮式生物反应器 片状载体 VERO细胞 乙型脑炎 灭活疫苗 Cellingen Plus Fibra disk Vero cells Japanese encephalitis Inactivated vaccine
  • 相关文献

参考文献10

二级参考文献41

共引文献67

同被引文献55

  • 1朱蓉,薛红刚,徐葛林.应用细胞法代替小鼠法检测狂犬病毒毒力[J].中国生物制品学杂志,2006,19(1):87-88. 被引量:9
  • 2俞永新.国内外狂犬病疫苗的发展和现状[J].上海预防医学,2006,18(5):216-218. 被引量:27
  • 3查力,高军,侯剑英,白珠穆,袁德明,杨俊伟,李旭,李庆岸,陈焕玉,孙非非,赵红梅,周德水.生物反应器细胞培养制备人用狂犬病疫苗[J].中国生物制品学杂志,2006,19(3):288-290. 被引量:20
  • 4杜丽娟,王世光,张立,陈尔佳,杨喆,包永明.两种方法纯化流感病毒的比较[J].中国生物制品学杂志,2007,20(3):216-218. 被引量:10
  • 5国家药典委员会.中国药典(三部)[s].北京:中国医药科技出版社,2010:111-114.
  • 6Singh H. Laboratory techniques in rabies (fourth edition). WHO Geneva : 1996.
  • 7Ark A, Vander Velden T, et al. A microearrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions [J]. Vaccine, 2007, 25 (19): 3879- 3889.
  • 8Frazzati-Gallina NM, Paoli RL, Mourao-Fuches RM, et al. Higher production of rabies virus in serum-free medium cell cultures on microcarriers [J ]. J Biotechnol, 2001, 92 (1): 67-72.
  • 9Qi u J. Enterovirus 71 infection: a new threat to global public health [J]. Lancet Neurol, 2008, 7 (10): 868-869.
  • 10Hart J, Ma X J, Xu WB, et al. EV71 viral secretion by symptomatic hand foot and mouth disease patients and their asymptomatic close contacts [J]. J Infect, 2011, 62 ( 1 ) : 107-108.

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部